Application value of the clinical curative effect for laparoscopic sleeve gastrectomy with duodeno- jejunal bypass to treat non-obese type 2 diabetes

殷骏,毛忠琦,徐露,朱政,陈昕,周晓俊,钱海鑫
DOI: https://doi.org/10.3877/cma.j.issn.2095-9605.2015.01.005
2015-01-01
Abstract:Objective To explore the clinical effectiveness and safety of laparoscopic sleeve gastrectomy-duodenojejunal bypass (LSG+DJB) in the non-obese diabetes patients.Methods The data of 12 non-obese patients with type 2 diabetes mellitus who underwent LSG+DJB from June 2012 to December 2013 were analyzed, including the length of hospitalization, operative time, blood loss, operative related complications and weight, BMI, waist circumference, fasting plasma glucose (FPG), oral glucose tolerance test, HbA1c, blood lipids and the changing of diabetes complications at pre and postoperative time of 1,3,6 and 12 months.Results All the procedures were preformed smoothly without perioperative death. Esophageal reflux symptoms such as heartburn happened to one case after the procedure, and released after conservative treatment. The FPG, HbA1c, HOMA-IR, C-peptide, weight, BMI, waist circumference, serum triglyceride (TG), low density lipoprotein cholesterol (LDL-C) of the patients were declined significantly after the procedure (P<0.05). One year after the procedures, 9 cases stopped taking medicine because of the remission of T2DM, including 3 cases completely cured (HbA1c<6.0%) and 6 cases controlled (HbA1c<7.0%), andthe other 3 cases decreased hypoglycemic agent.Conclusions LSG+DJB performed safely in non-obese patients with type 2 diabetes with the good effectiveness of controlling weights, improving blood glucose, blood lipid and related complications. The short-term effectiveness is good, but the long-term effectiveness remains further observation.
What problem does this paper attempt to address?